NOF Polysorbate 80 is in compliance with the Chinese Pharmacopoeia
We are pleased to inform you that we submitted a drug master file to CDE (Center for Drug Evaluation, National Medical Products Administration) for our Polysorbate 80 (HX2)TM .
Polysorbate 80 (HX2)TM, which is our ultrapure polysorbate 80, is now in compliance with the United States Pharmacopeia [USP], the European Pharmacopoeia [EP], the Japanese Pharmacopoeia [JP], and the Chinese Pharmacopoeia [ChP for injection].
You can use Polysorbate 80 (HX2)TM for development of various pharmaceutical products for the Chinese market.
No posts found